These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 18055804)

  • 1. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
    Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
    Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
    Meyer-Ter-Vehn T; Gebhardt S; Sebald W; Buttmann M; Grehn F; Schlunck G; Knaus P
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1500-9. PubMed ID: 16565385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
    Van de Velde S; Van Bergen T; Vandewalle E; Kindt N; Castermans K; Moons L; Stalmans I
    Prog Brain Res; 2015; 220():283-97. PubMed ID: 26497796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells.
    Koga T; Koga T; Awai M; Tsutsui J; Yue BY; Tanihara H
    Exp Eye Res; 2006 Mar; 82(3):362-70. PubMed ID: 16125171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
    Ibrahim DG; Ko JA; Iwata W; Okumichi H; Kiuchi Y
    Cell Biochem Funct; 2019 Mar; 37(2):113-124. PubMed ID: 30773659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro.
    Tura A; Grisanti S; Petermeier K; Henke-Fahle S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2152-61. PubMed ID: 17460274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
    Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BY; Narumiya S; Honda Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):137-44. PubMed ID: 11133858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction by latanoprost of collagen gel contraction mediated by human tenon fibroblasts: role of intracellular signaling molecules.
    Liu Y; Ko JA; Yanai R; Kimura K; Chikama T; Sagara T; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1429-36. PubMed ID: 18385060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
    Rao PV; Deng PF; Kumar J; Epstein DL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.
    Cordeiro MF; Gay JA; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2225-34. PubMed ID: 10476787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery.
    Eibl KH; Banas B; Kook D; Ohlmann AV; Priglinger S; Kampik A; Welge-Luessen UC
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2619-24. PubMed ID: 15277485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy.
    Shi H; Wang H; Fu S; Xu K; Zhang X; Xiao Y; Ye W
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1478-1486. PubMed ID: 28273314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of specific ROCK inhibitor in the prevention of experimental PVR in rabbits].
    Zheng YP; Sun NX; Xiong QC; Quan YL; Wang F
    Zhonghua Yan Ke Za Zhi; 2005 Dec; 41(12):1112-8. PubMed ID: 16409766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
    Chen YH; Liang CM; Chen CL; Chen JT; Chang YH; Lu DW; Chien KH; Tai MC
    Acta Ophthalmol; 2013 Nov; 91(7):e506-15. PubMed ID: 23764119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
    Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.
    Ko JA; Komatsu K; Minamoto A; Kondo S; Okumichi H; Hirooka K; Kiuchi Y
    Curr Eye Res; 2023 Sep; 48(9):826-835. PubMed ID: 37216470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of trehalose on fibroblast proliferation and implications for ocular surgery.
    Takeuchi K; Nakazawa M; Ebina Y; Sato K; Metoki T; Miyagawa Y; Ito T
    Exp Eye Res; 2010 Nov; 91(5):567-77. PubMed ID: 20650271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.
    Yamamoto M; Quantock AJ; Young RD; Okumura N; Ueno M; Sakamoto Y; Kinoshita S; Koizumi N
    Mol Vis; 2012; 18():1727-39. PubMed ID: 22815626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis.
    Nakagawa H; Yoshioka K; Miyahara E; Fukushima Y; Tamura M; Itoh K
    Mol Cancer Res; 2005 Aug; 3(8):425-33. PubMed ID: 16123138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.